Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Change in Accured Expenses: 2019-2024

Historic Change in Accured Expenses for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to -$8.1 million.

  • P3 Health Partners' Change in Accured Expenses rose 5626.06% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 45515.5%. This contributed to the annual value of -$8.1 million for FY2024, which is 15066.93% down from last year.
  • Per P3 Health Partners' latest filing, its Change in Accured Expenses stood at -$8.1 million for FY2024, which was down 15066.93% from $16.0 million recorded in FY2023.
  • P3 Health Partners' Change in Accured Expenses' 5-year high stood at $34.2 million during FY2021, with a 5-year trough of -$8.1 million in FY2024.
  • Its 5-year average for Change in Accured Expenses is $10.1 million, with a median of $6.1 million in 2022.
  • In the last 5 years, P3 Health Partners' Change in Accured Expenses skyrocketed by 16287.41% in 2023 and then tumbled by 15066.93% in 2024.
  • P3 Health Partners' Change in Accured Expenses (Annual) stood at $2.3 million in 2020, then soared by 1394.72% to $34.2 million in 2021, then tumbled by 82.23% to $6.1 million in 2022, then soared by 162.87% to $16.0 million in 2023, then tumbled by 150.67% to -$8.1 million in 2024.
  • Its last three reported values are -$8.1 million in FY2024, $16.0 million for FY2023, and $6.1 million during FY2022.